iFeel Labs

Company Overview

Snapshot

Founded in January 2014 by Elad Fein and Keren Sereno Fein, iFeel Labs operates with 1–10 employees. The company focuses on transforming popular mobile games into biosense games that guide users in effective breathing. In December 2015, iFeel Labs was highlighted for its innovative approach to physical therapy, emphasizing the integration of fun into therapeutic processes.

Business overview

iFeel Labs develops respiratory digital therapy designed to monitor and prevent stress, anxiety, and pulmonary exacerbation. The company's core technology transforms popular mobile games and applications into biosense games, where user progression is linked to healthy breathing patterns. Utilizing wearable sensors to track real-time pulse data, its smartphone applications guide users in effective breathing and monitor pulmonary exacerbation biomarkers. iFeel Labs serves patients in the digital healthcare sector, aiming to mitigate the effects of stress, anxiety, depression, PTSD, and insomnia, and to assist asthma and COPD patients in monitoring and preventing pulmonary exacerbation.

Strategic signal

In April 2018, iFeel Labs gained attention for its efforts to combat student stress through games, indicating a strategic focus on expanding its digital therapy applications beyond traditional clinical settings. This highlights the company's potential to address mental well-being and stress management in broader consumer markets, signaling a versatile and scalable approach to digital therapeutics.

Company Intelligence Q&A

What is iFeel Labs' primary focus?

iFeel Labs primarily focuses on developing respiratory digital therapy for monitoring and preventing stress, anxiety, and pulmonary exacerbation, transforming mobile games into biosense games for therapeutic purposes.

When was iFeel Labs founded and by whom?

iFeel Labs was founded in January 2014 by co-founders Elad Fein and Keren Sereno Fein.

How does iFeel Labs' technology work?

iFeel Labs' solution uses wearable sensors to track pulse data in real time, while smartphone applications guide users in effective breathing and monitor pulmonary exacerbation biomarkers.

What markets does iFeel Labs target?

iFeel Labs targets markets in India, the United States, and Israel, serving patients with conditions such as asthma, COPD, stress, anxiety, depression, PTSD, and insomnia.

What was a notable recognition for iFeel Labs in 2015?

In December 2015, iFeel Labs was recognized by www.israel21c.org for being among Israeli companies that integrate fun into physical therapy.